Immunotherapy in Urothelial Carcinoma

Immunotherapy in Urothelial Carcinoma

Budget is limited to $50,000 - Expiry date is April 12, 2022

Pfizer
The intent of this RFP is to support independent education initiatives for healthcare professionals involved in the treatment of patients with locally advanced or metastatic urothelial carcinoma...

Funding Opportunity

Visit the funding page (members only, sign in): Immunotherapy in Urothelial Carcinoma

Sign in or register for free to read the full details and apply

Sign in Create a free account

Share:

All funding opportunities